Ingalls & Snyder’s Sensus Healthcare SRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTS
Ingalls & Snyder's SRTS Position: Q3 2026 in Review
Ingalls & Snyder held its Sensus Healthcare (SRTS) position steady in Q3 2026 at 55,000 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #443.
Ingalls & Snyder first reported a position in SRTS in Q4 2025 and has held it in 4 quarters since. The position peaked at $219K in Q1 2026. 37 funds tracked by Wall St. Rank hold SRTS as of Q3 2026.
- Ingalls & Snyder held 55,000 shares of Sensus Healthcare worth $164K as of Q3 2026.
- Ingalls & Snyder left its Sensus Healthcare share count unchanged in Q3 2026.
- Sensus Healthcare made up ﹤0.01% of Ingalls & Snyder's portfolio in Q3 2026, its #443 holding.
- Ingalls & Snyder first reported a position in Sensus Healthcare in Q4 2025 and has held it in 4 quarters since.
- Ingalls & Snyder's Sensus Healthcare position peaked at $219K in Q1 2026.
- 37 funds tracked by Wall St. Rank held Sensus Healthcare as of Q3 2026.
Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.